Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Gynecol Oncol. 2017 Jul 10;147(1):145–152. doi: 10.1016/j.ygyno.2017.07.009

Figure 2.

Figure 2

Figure 2

Proliferation assay results demonstrating % viable cells for three HER2/neu 3+ overexpressing cell lines and one HER2/neu 1+/0 expressing control cell line (i.e., OVA4). T-DM1 significantly inhibited in vitro EOC proliferation compared to other groups (p<0.0001).